Ruled out of preeclampsia ‐like syndrome due to COVID‐19: A case study
In this study, we report a 28-year-old pregnant woman who had a postpartum seizure with a background of HELLP syndrome and a proven COVID-19 infection. Her child survived, and at 12-week postpartum, all maternal COVID-19 –related symptoms vanished, and she was cured.
The objective of this study is to describe the impact of maternal COVID-19 severity on placental vasculature.
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 with a spectrum of disease outcomes in pregnancy and rare congenital infections. Viral tropism for cells in placental tissues is suggested to be low, but SARS-CoV-2 prevalence in placental tissues from women with COVID-19 is unknown. The placenta can produce a robust antiviral innate immune response, though it is unknown whether SARS-CoV-2 induces placental innate immunity and pathologic changes. Though SARS-CoV-2 detection in placental tissues is thought to be infrequent, immune factors associated with viral persistence are unknown.
Emerging data during the COVID-19 pandemic have shown positive RT-PCR testing in asymptomatic people may reflect prolonged shedding of viral RNA rather than active infection. IgG avidity is helpful to determine the timing of infection in other illnesses. We aimed to understand the evolution of IgG avidity over time after COVID-19 infection in a cohort of pregnant people and their newborns.
After observing unexpectedly high rates of pregnancy complications in patients with COVID-19, we performed a retrospective review to identify if severe maternal morbidity (SMM) was more common among pregnant women with COVID-19 in our tertiary care obstetric service.
The objective of this study was to measure the prevalence of SARs-CoV-2 viral infection among pregnant women seeking care at two rural federally qualified health centers primary in NC.
To assess influenza and COVID-19 vaccine hesitancy among pregnant women based on the core constructs of the Health Belief Model (HBM).
To determine the prevalence of COVID-19 vaccine hesitancy among pregnant women during the pandemic and to identify patient characteristics, attitudes and experiences that increase hesitancy.
The purpose of this study is to investigate the relationship between maternal morbidity, socioeconomic status (SES), and race/ethnicity among pregnant women testing positive for COVID-19 prior to delivery.
Individuals with moderate to severe depressive symptoms are more likely to say they believe misinformation about COVID-19 vaccines than those without depressive symptoms, according to areport in JAMA Open Network. Moreover, individuals who believed misinformation about COVID vaccines were less likely to be vaccinated or be willing to get the vaccine.“As such, individuals already burdened with depression may be at a higher risk of COVID-19,” wrote lead author Roy H. Perlis, M.D., M.Sc., of Massachusetts General Hospital and colleagues.The researchers analyzed data from U.S. adults who responded to at least one o...
An NHS England letter has warned of “significant variation” in the uptake of the covid-19 vaccine amongst pregnant women, and called on systems to enable more “spontaneous” antenatal vaccination.